APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hirudin

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Selected research

Industry Research

Hirudin Industry Research Report 2026

1 January 2026122 pages

Choose your research edition.

Industry ResearchHirudin Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hirudin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Hirudin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hirudin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hirudin Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

Report Scope

Read the full market overview

This report quantifies the global Hirudin market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Hirudin.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Hirudin Market by Company

The Medicines Company

Keyken

Minapharm

Abbott

SALUBRIS

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

DUOPUTAI

Pentapharm

Hirudin Segment by Type

Natural Hirudin

Recombinant Hirudin

Hirudin Segment by Application

Thrombosis Disease

Tumor Disease

Others

Hirudin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hirudin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hirudin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hirudin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hirudin Production by Manufacturers (MT) & (2021-2026) Table 6. Global Hirudin Production Market Share by Manufacturers Table 7. Global Hirudin Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Hirudin Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Hirudin Average Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Hirudin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hirudin Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Hirudin Manufacturers, Product Type & Application Table 13. Global Hirudin Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hirudin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. The Medicines Company Company Information Table 18. The Medicines Company Business Overview Table 19. The Medicines Company Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 20. The Medicines Company Hirudin Product Portfolio Table 21. The Medicines Company Recent Development Table 22. Keyken Company Information Table 23. Keyken Business Overview Table 24. Keyken Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 25. Keyken Hirudin Product Portfolio Table 26. Keyken Recent Development Table 27. Minapharm Company Information Table 28. Minapharm Business Overview Table 29. Minapharm Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 30. Minapharm Hirudin Product Portfolio Table 31. Minapharm Recent Development Table 32. Abbott Company Information Table 33. Abbott Business Overview Table 34. Abbott Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 35. Abbott Hirudin Product Portfolio Table 36. Abbott Recent Development Table 37. SALUBRIS Company Information Table 38. SALUBRIS Business Overview Table 39. SALUBRIS Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 40. SALUBRIS Hirudin Product Portfolio Table 41. SALUBRIS Recent Development Table 42. Pfizer, Inc Company Information Table 43. Pfizer, Inc Business Overview Table 44. Pfizer, Inc Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Pfizer, Inc Hirudin Product Portfolio Table 46. Pfizer, Inc Recent Development Table 47. Teva Pharmaceutical Industries Ltd Company Information Table 48. Teva Pharmaceutical Industries Ltd Business Overview Table 49. Teva Pharmaceutical Industries Ltd Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 50. Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio Table 51. Teva Pharmaceutical Industries Ltd Recent Development Table 52. DUOPUTAI Company Information Table 53. DUOPUTAI Business Overview Table 54. DUOPUTAI Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 55. DUOPUTAI Hirudin Product Portfolio Table 56. DUOPUTAI Recent Development Table 57. Pentapharm Company Information Table 58. Pentapharm Business Overview Table 59. Pentapharm Hirudin Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 60. Pentapharm Hirudin Product Portfolio Table 61. Pentapharm Recent Development Table 62. Global Hirudin Production Comparison by Region: 2021 VS 2025 VS 2032 (MT) Table 63. Global Hirudin Production by Region (2021-2026) & (MT) Table 64. Global Hirudin Production Market Share by Region (2021-2026) Table 65. Global Hirudin Production Forecast by Region (2027-2032) & (MT) Table 66. Global Hirudin Production Market Share Forecast by Region (2027-2032) Table 67. Global Hirudin Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Hirudin Production Value by Region (2021-2026) & (US$ Million) Table 69. Global Hirudin Production Value Market Share by Region (2021-2026) Table 70. Global Hirudin Production Value Forecast by Region (2027-2032) & (US$ Million) Table 71. Global Hirudin Market Average Price (USD/Kg) by Region (2021-2026) Table 72. Global Hirudin Market Average Price (USD/Kg) by Region (2027-2032) Table 73. Global Hirudin Consumption Comparison by Region: 2021 VS 2025 VS 2032 (MT) Table 74. Global Hirudin Consumption by Region (2021-2026) & (MT) Table 75. Global Hirudin Consumption Market Share by Region (2021-2026) Table 76. Global Hirudin Forecasted Consumption by Region (2027-2032) & (MT) Table 77. Global Hirudin Forecasted Consumption Market Share by Region (2027-2032) Table 78. North America Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 79. North America Hirudin Consumption by Country (2021-2026) & (MT) Table 80. North America Hirudin Consumption by Country (2027-2032) & (MT) Table 81. Europe Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 82. Europe Hirudin Consumption by Country (2021-2026) & (MT) Table 83. Europe Hirudin Consumption by Country (2027-2032) & (MT) Table 84. Asia Pacific Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 85. Asia Pacific Hirudin Consumption by Country (2021-2026) & (MT) Table 86. Asia Pacific Hirudin Consumption by Country (2027-2032) & (MT) Table 87. South America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 88. South America, Middle East & Africa Hirudin Consumption by Country (2021-2026) & (MT) Table 89. South America, Middle East & Africa Hirudin Consumption by Country (2027-2032) & (MT) Table 90. Global Hirudin Production by Type (2021-2026) & (MT) Table 91. Global Hirudin Production by Type (2027-2032) & (MT) Table 92. Global Hirudin Production Market Share by Type (2021-2026) Table 93. Global Hirudin Production Market Share by Type (2027-2032) Table 94. Global Hirudin Production Value by Type (2021-2026) & (US$ Million) Table 95. Global Hirudin Production Value by Type (2027-2032) & (US$ Million) Table 96. Global Hirudin Production Value Market Share by Type (2021-2026) Table 97. Global Hirudin Production Value Market Share by Type (2027-2032) Table 98. Global Hirudin Price by Type (2021-2026) & (USD/Kg) Table 99. Global Hirudin Price by Type (2027-2032) & (USD/Kg) Table 100. Global Hirudin Production by Application (2021-2026) & (MT) Table 101. Global Hirudin Production by Application (2027-2032) & (MT) Table 102. Global Hirudin Production Market Share by Application (2021-2026) Table 103. Global Hirudin Production Market Share by Application (2027-2032) Table 104. Global Hirudin Production Value by Application (2021-2026) & (US$ Million) Table 105. Global Hirudin Production Value by Application (2027-2032) & (US$ Million) Table 106. Global Hirudin Production Value Market Share by Application (2021-2026) Table 107. Global Hirudin Production Value Market Share by Application (2027-2032) Table 108. Global Hirudin Price by Application (2021-2026) & (USD/Kg) Table 109. Global Hirudin Price by Application (2027-2032) & (USD/Kg) Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Hirudin Distributors List Table 113. Hirudin Customers List Table 114. Hirudin Industry Trends Table 115. Hirudin Industry Drivers Table 116. Hirudin Industry Restraints Table 117. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Hirudin Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Natural Hirudin Product Image Figure 7. Recombinant Hirudin Product Image Figure 8. Thrombosis Disease Product Image Figure 9. Tumor Disease Product Image Figure 10. Others Product Image Figure 11. Global Hirudin Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Hirudin Production Value (2021-2032) & (US$ Million) Figure 13. Global Hirudin Production Capacity (2021-2032) & (MT) Figure 14. Global Hirudin Production (2021-2032) & (MT) Figure 15. Global Hirudin Average Price (USD/Kg) & (2021-2032) Figure 16. Global Hirudin Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Hirudin Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Hirudin Production Comparison by Region: 2021 VS 2025 VS 2032 (MT) Figure 20. Global Hirudin Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Hirudin Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Hirudin Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Hirudin Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Hirudin Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Hirudin Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Hirudin Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global Hirudin Consumption Comparison by Region: 2021 VS 2025 VS 2032 (MT) Figure 28. Global Hirudin Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 30. North America Hirudin Consumption Market Share by Country (2021-2032) Figure 31. United States Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 32. United States Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 33. Canada Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 34. Mexico Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 35. Europe Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 36. Europe Hirudin Consumption Market Share by Country (2021-2032) Figure 37. Germany Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 38. France Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 39. U.K. Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 40. Italy Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 41. Russia Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 42. Spain Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 43. Netherlands Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 44. Switzerland Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 45. Sweden Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 46. Poland Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 47. Asia Pacific Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 48. Asia Pacific Hirudin Consumption Market Share by Country (2021-2032) Figure 49. China Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 50. Japan Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 51. South Korea Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 52. India Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 53. Australia Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 54. Taiwan Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 55. Southeast Asia Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 56. South America, Middle East & Africa Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 57. South America, Middle East & Africa Hirudin Consumption Market Share by Country (2021-2032) Figure 58. Brazil Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 59. Argentina Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 60. Chile Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 61. Turkey Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 62. GCC Countries Hirudin Consumption and Growth Rate (2021-2032) & (MT) Figure 63. Global Hirudin Production Market Share by Type (2021-2032) Figure 64. Global Hirudin Production Value Market Share by Type (2021-2032) Figure 65. Global Hirudin Price (USD/Kg) by Type (2021-2032) Figure 66. Global Hirudin Production Market Share by Application (2021-2032) Figure 67. Global Hirudin Production Value Market Share by Application (2021-2032) Figure 68. Global Hirudin Price (USD/Kg) by Application (2021-2032) Figure 69. Hirudin Value Chain Figure 70. Hirudin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Hirudin Industry Opportunities and Challenges

Scope & coverage.

Types
  • Natural Hirudin
  • Recombinant Hirudin
Applications
  • Thrombosis Disease
  • Tumor Disease
  • Others
Companies covered
  • The Medicines Company
  • Keyken
  • Minapharm
  • Abbott
  • SALUBRIS
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • DUOPUTAI
  • Pentapharm

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Hirudin by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Natural Hirudin
  5. 2.2.3 Recombinant Hirudin
  6. 2.3 Hirudin by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Thrombosis Disease
  9. 2.3.3 Tumor Disease
  10. 2.3.4 Others
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Hirudin Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Hirudin Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Hirudin Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Hirudin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Hirudin Production by Manufacturers (2021-2026)
  2. 3.2 Global Hirudin Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Hirudin Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Hirudin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hirudin Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Hirudin Manufacturers, Product Type & Application
  7. 3.7 Global Hirudin Manufacturers Established Date
  8. 3.8 Global Hirudin Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 The Medicines Company
  2. 4.1.1 The Medicines Company Hirudin Company Information
  3. 4.1.2 The Medicines Company Hirudin Business Overview
  4. 4.1.3 The Medicines Company Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 The Medicines Company Product Portfolio
  6. 4.1.5 The Medicines Company Recent Developments
  7. 4.2 Keyken
  8. 4.2.1 Keyken Hirudin Company Information
  9. 4.2.2 Keyken Hirudin Business Overview
  10. 4.2.3 Keyken Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Keyken Product Portfolio
  12. 4.2.5 Keyken Recent Developments
  13. 4.3 Minapharm
  14. 4.3.1 Minapharm Hirudin Company Information
  15. 4.3.2 Minapharm Hirudin Business Overview
  16. 4.3.3 Minapharm Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Minapharm Product Portfolio
  18. 4.3.5 Minapharm Recent Developments
  19. 4.4 Abbott
  20. 4.4.1 Abbott Hirudin Company Information
  21. 4.4.2 Abbott Hirudin Business Overview
  22. 4.4.3 Abbott Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Abbott Product Portfolio
  24. 4.4.5 Abbott Recent Developments
  25. 4.5 SALUBRIS
  26. 4.5.1 SALUBRIS Hirudin Company Information
  27. 4.5.2 SALUBRIS Hirudin Business Overview
  28. 4.5.3 SALUBRIS Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 SALUBRIS Product Portfolio
  30. 4.5.5 SALUBRIS Recent Developments
  31. 4.6 Pfizer, Inc
  32. 4.6.1 Pfizer, Inc Hirudin Company Information
  33. 4.6.2 Pfizer, Inc Hirudin Business Overview
  34. 4.6.3 Pfizer, Inc Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer, Inc Product Portfolio
  36. 4.6.5 Pfizer, Inc Recent Developments
  37. 4.7 Teva Pharmaceutical Industries Ltd
  38. 4.7.1 Teva Pharmaceutical Industries Ltd Hirudin Company Information
  39. 4.7.2 Teva Pharmaceutical Industries Ltd Hirudin Business Overview
  40. 4.7.3 Teva Pharmaceutical Industries Ltd Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Teva Pharmaceutical Industries Ltd Product Portfolio
  42. 4.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
  43. 4.8 DUOPUTAI
  44. 4.8.1 DUOPUTAI Hirudin Company Information
  45. 4.8.2 DUOPUTAI Hirudin Business Overview
  46. 4.8.3 DUOPUTAI Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 DUOPUTAI Product Portfolio
  48. 4.8.5 DUOPUTAI Recent Developments
  49. 4.9 Pentapharm
  50. 4.9.1 Pentapharm Hirudin Company Information
  51. 4.9.2 Pentapharm Hirudin Business Overview
  52. 4.9.3 Pentapharm Hirudin Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Pentapharm Product Portfolio
  54. 4.9.5 Pentapharm Recent Developments
5 Global Hirudin Production by Region
  1. 5.1 Global Hirudin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Hirudin Production by Region: 2021-2032
  3. 5.2.1 Global Hirudin Production by Region: 2021-2026
  4. 5.2.2 Global Hirudin Production Forecast by Region (2027-2032)
  5. 5.3 Global Hirudin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Hirudin Production Value by Region: 2021-2032
  7. 5.4.1 Global Hirudin Production Value by Region: 2021-2026
  8. 5.4.2 Global Hirudin Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Hirudin Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Hirudin Production and Value, YOY Growth
  11. 5.6.1 North America Hirudin Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Hirudin Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Hirudin Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Hirudin Production Value Estimates and Forecasts (2021-2032)
6 Global Hirudin Consumption by Region
  1. 6.1 Global Hirudin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hirudin Consumption by Region (2021-2032)
  3. 6.2.1 Global Hirudin Consumption by Region: 2021-2026
  4. 6.2.2 Global Hirudin Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hirudin Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hirudin Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Hirudin Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Hirudin Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Hirudin Production by Type (2021-2032)
  2. 7.1.1 Global Hirudin Production by Type (2021-2032) & (MT)
  3. 7.1.2 Global Hirudin Production Market Share by Type (2021-2032)
  4. 7.2 Global Hirudin Production Value by Type (2021-2032)
  5. 7.2.1 Global Hirudin Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Hirudin Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Hirudin Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Hirudin Production by Application (2021-2032)
  2. 8.1.1 Global Hirudin Production by Application (2021-2032) & (MT)
  3. 8.1.2 Global Hirudin Production Market Share by Application (2021-2032)
  4. 8.2 Global Hirudin Production Value by Application (2021-2032)
  5. 8.2.1 Global Hirudin Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Hirudin Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Hirudin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Hirudin Value Chain Analysis
  2. 9.1.1 Hirudin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Hirudin Production Mode & Process
  5. 9.2 Hirudin Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Hirudin Distributors
  8. 9.2.3 Hirudin Customers
10 Global Hirudin Analyzing Market Dynamics
  1. 10.1 Hirudin Industry Trends
  2. 10.2 Hirudin Industry Drivers
  3. 10.3 Hirudin Industry Opportunities and Challenges
  4. 10.4 Hirudin Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst